APAC to emerge as key player in the global AI oncology market

Its growth is fuelled by rapid technological advancements and increased healthcare investments.

The Asia Pacific (APAC) region is poised to emerge as a key player in the global AI oncology market, which is projected to reach $7.7b in sales revenue by the end of 2034, according to Transparency Market Research.

The region’s growth is attributed to rapid technological advancements and increased healthcare investments.

Countries such as China, Japan, and South Korea are investing in AI-based diagnostics and treatment to address the rising burden of cancer.

Moreover, collaborations between technology firms, healthcare organisations, and government agencies are further driving the APAC landscape.

Overall, the demand for accurate diagnosis and personalised treatment is propelling the use of AI in the field of oncology.